Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis
Open Access
- 7 August 2001
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (8) , 1754-1760
- https://doi.org/10.1002/1529-0131(200108)44:8<1754::aid-art310>3.0.co;2-8
Abstract
Objective To investigate the role of proinflammatory cytokines, vascular endothelial growth factor (VEGF), matrix metalloproteinases (MMPs), and tissue inhibitor of metalloproteinases 1 (TIMP‐1) in the destruction of tendons by tenosynovium in rheumatoid arthritis (RA). Methods Synovial specimens were obtained from encapsulating tenosynovium (n = 17), invasive tenosynovium (n = 13), and wrist joints (n = 17) in 18 RA patients undergoing wrist extensor tenosynovectomy. Synovial membrane cells were dissociated from connective tissue by enzyme digestion and cultured in vitro for 48 hours, and harvested supernatants were assayed for the cytokines tumor necrosis factor α (TNFα) and interleukin‐6 (IL‐6), VEGF, MMPs 1, 2, 3, and 13, and TIMP‐1 by enzyme‐linked immunosorbent assay. Gelatin zymography was performed to demonstrate enzyme activity. Statistical analysis was performed using Student's paired 2‐tailed t‐tests for parametric data and the Wilcoxon signed rank test for nonparametric data. Results MMP‐1 and MMP‐13 levels were ∼2.5‐fold higher in invasive tenosynovium compared with encapsulating tenosynovium. Levels of MMP‐2 were ∼1.5‐fold higher in invasive tenosynovium compared with both encapsulating tenosynovium and wrist joint synovium. MMP‐13 (P = 0.009) and IL‐6 (P = 0.03) levels were significantly lower in encapsulating tenosynovium compared with wrist joint synovium. Levels of VEGF, TIMP‐1, TNFα, and MMP‐3 were similar in all synovial sample groups. Zymography demonstrated enzyme activity in all synovium samples from all 9 patients assessed. Conclusion Tenosynovium produces proinflammatory cytokines and proteolytic enzymes that are important in the tissue degradation seen in RA. Increased production of the enzymes MMP‐1, MMP‐2, and MMP‐13 by invasive tenosynovium suggests a possible explanation for the worse prognosis and increased rupture rate associated with invasive tenosynovitis in RA. Production of VEGF by tenosynovium suggests that angiogenesis may have a role in tenosynovial proliferation and invasion of tendons.Keywords
This publication has 11 references indexed in Scilit:
- Human shoulder tendon biopsy samples in organ culture produce procollagenase and tissue inhibitor of metalloproteinases.Annals of the Rheumatic Diseases, 1995
- Matrix Metalloproteinase-2 Is an Interstitial CollagenaseJournal of Biological Chemistry, 1995
- Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?Arthritis & Rheumatism, 1994
- Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritisThe Lancet, 1994
- Role of cytokines in experimental arthritisClinical and Experimental Immunology, 1994
- Ultrastructural Causes of Rupture of Hand Tendons in Patients with Rheumatoid ArthritisA transmission and scanning electron microscopic studyScandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 1993
- Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cellsBiochemical Journal, 1992
- Flexor tendon ruptures in patients with rheumatoid arthritisThe Journal of Hand Surgery, 1988
- Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritidesArthritis & Rheumatism, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988